These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 29193875)
1. Dabigatran inhibits intravitreal thrombin activity. Bastiaans J; Mulder VC; van Meurs JC; Smits-Te Nijenhuis M; van Holten-Neelen C; van Hagen PM; Dik WA Acta Ophthalmol; 2018 Aug; 96(5):452-458. PubMed ID: 29193875 [TBL] [Abstract][Full Text] [Related]
2. The role of thrombin in proliferative vitreoretinopathy. Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355 [TBL] [Abstract][Full Text] [Related]
3. Factor Xa and thrombin stimulate proinflammatory and profibrotic mediator production by retinal pigment epithelial cells: a role in vitreoretinal disorders? Bastiaans J; van Meurs JC; van Holten-Neelen C; Nijenhuis MS; Kolijn-Couwenberg MJ; van Hagen PM; Kuijpers RW; Hooijkaas H; Dik WA Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1723-33. PubMed ID: 23604512 [TBL] [Abstract][Full Text] [Related]
4. Vitreous and subretinal fluid concentrations of orally administered dabigatran in patients with rhegmatogenous retinal detachment. Mulder VC; Kluft C; van Meurs JC Acta Ophthalmol; 2016 Nov; 94(7):663-667. PubMed ID: 27496339 [TBL] [Abstract][Full Text] [Related]
5. Thrombin induces epithelial-mesenchymal transition and collagen production by retinal pigment epithelial cells via autocrine PDGF-receptor signaling. Bastiaans J; van Meurs JC; van Holten-Neelen C; Nagtzaam NM; van Hagen PM; Chambers RC; Hooijkaas H; Dik WA Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8306-14. PubMed ID: 24302586 [TBL] [Abstract][Full Text] [Related]
6. A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy. Lei H; Hovland P; Velez G; Haran A; Gilbertson D; Hirose T; Kazlauskas A Invest Ophthalmol Vis Sci; 2007 May; 48(5):2335-42. PubMed ID: 17460299 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy. El-Ghrably IA; Dua HS; Orr GM; Fischer D; Tighe PJ Br J Ophthalmol; 2001 Apr; 85(4):461-70. PubMed ID: 11264138 [TBL] [Abstract][Full Text] [Related]
8. Notch signaling modulates proliferative vitreoretinopathy via regulating retinal pigment epithelial-to-mesenchymal transition. Zhang J; Yuan G; Dong M; Zhang T; Hua G; Zhou Q; Shi W Histochem Cell Biol; 2017 Mar; 147(3):367-375. PubMed ID: 27600720 [TBL] [Abstract][Full Text] [Related]
9. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy. Canataroglu H; Varinli I; Ozcan AA; Canataroglu A; Doran F; Varinli S Ocul Immunol Inflamm; 2005; 13(5):375-81. PubMed ID: 16422002 [TBL] [Abstract][Full Text] [Related]
10. BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro. Yao H; Ge T; Zhang Y; Li M; Yang S; Li H; Wang F FASEB J; 2019 Mar; 33(3):3212-3224. PubMed ID: 30383450 [TBL] [Abstract][Full Text] [Related]
11. The influence of systemic renin-angiotensin-inhibition on ocular cytokines related to proliferative vitreoretinopathy. Hoerster R; Fauser S; Cursiefen C; Kirchhof B; Heindl LM Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1721-1725. PubMed ID: 28600710 [TBL] [Abstract][Full Text] [Related]
12. The effects of pleiotrophin in proliferative vitreoretinopathy. Ding X; Bai Y; Zhu X; Li T; Jin E; Huang L; Yu W; Zhao M Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):873-884. PubMed ID: 28083679 [TBL] [Abstract][Full Text] [Related]
13. Altered Decorin Biology in Proliferative Vitreoretinopathy: A Mechanistic and Cohort Study. Begum G; O'Neill J; Chaudhary R; Blachford K; Snead DRJ; Berry M; Scott RAH; Logan A; Blanch RJ Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):4929-4936. PubMed ID: 30347087 [TBL] [Abstract][Full Text] [Related]
14. Vitreous M2 Macrophage-Derived Microparticles Promote RPE Cell Proliferation and Migration in Traumatic Proliferative Vitreoretinopathy. Song Y; Liao M; Zhao X; Han H; Dong X; Wang X; Du M; Yan H Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):26. PubMed ID: 34554178 [TBL] [Abstract][Full Text] [Related]
15. Effects of Curcumin on Epidermal Growth Factor in Proliferative Vitreoretinopathy. Ren YX; Ma JX; Zhao F; An JB; Geng YX; Liu LY Cell Physiol Biochem; 2018; 47(5):2136-2146. PubMed ID: 29975931 [TBL] [Abstract][Full Text] [Related]
16. Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy. Zhou G; Duan Y; Ma G; Wu W; Hu Z; Chen N; Chee Y; Cui J; Samad A; Matsubara JA; Mukai S; D'Amore PA; Lei H Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5361-5367. PubMed ID: 29049737 [TBL] [Abstract][Full Text] [Related]
17. Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders. Banerjee S; Savant V; Scott RA; Curnow SJ; Wallace GR; Murray PI Invest Ophthalmol Vis Sci; 2007 May; 48(5):2203-7. PubMed ID: 17460280 [TBL] [Abstract][Full Text] [Related]
18. Plasmin is the major protease responsible for processing PDGF-C in the vitreous of patients with proliferative vitreoretinopathy. Lei H; Velez G; Hovland P; Hirose T; Kazlauskas A Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):42-8. PubMed ID: 18172073 [TBL] [Abstract][Full Text] [Related]